Patients with osteoarthritis undergoing knee replacement have been reported to have an overall reduced mortality compared with that of the general population. This has been attributed to the selection of healthier patients for surgery. However, previous studies have had a maximum follow-up time of ten years. We have used information from the Swedish Knee Arthroplasty Register to study the mortality of a large national series of patients with total knee replacement for up to 28 years after surgery and compared their mortality with that of the normal population. In addition, for a subgroup of patients operated on between 1980 and 2002 we analysed their registered causes of death to determine if they differed from those expected.
Patients with osteoarthritis undergoing knee replacement have been reported to have an overall reduced mortality compared with that of the general population. This has been attributed to the selection of healthier patients for surgery. However, previous studies have had a maximum follow-up time of ten years. We have used information from the Swedish Knee Arthroplasty Register to study the mortality of a large national series of patients with total knee replacement for up to 28 years after surgery and compared their mortality with that of the normal population. In addition, for a subgroup of patients operated on between 1980 and 2002 we analysed their registered causes of death to determine if they differed from those expected.
We found a reduced overall mortality during the first 12 post-operative years after which it increased and became significantly higher than that of the general population. Agespecific analysis indicated an inverse correlation between age and mortality, where the younger the patients were, the higher their mortality. The shift at 12 years was caused by a relative over-representation of younger patients with a longer follow-up. Analysis of specific causes of death showed a higher mortality for cardiovascular, gastrointestinal and urogenital diseases. The observation that early onset of osteoarthritis of the knee which has been treated by total knee replacement is linked to an increased mortality should be a reason for increased general awareness of health problems in these patients.
Total hip and total knee replacements (THR, TKR) are usually performed on the elderly and are associated with some operative risk. Although reports on early post-operative mortality after TKR have been somewhat divergent, 1,2 several studies have reported an increased overall longevity in patients with osteoarthritis undergoing joint replacement. [3] [4] [5] [6] Commonly, this has been interpreted as a consequence of selecting comparatively healthy patients for surgery. However, the Norwegian Arthroplasty Register has also reported that young patients with THR for osteoarthritis have an increased ten-year mortality rate compared with that of the general population. 3 The Swedish Knee Arthroplasty Register, established in 1975, is the oldest national arthroplasty register, thereby allowing us to examine the mortality and underlying diseases causing death in patients with TKR over a longer period than has been previously reported.
Patients and Methods
The Register considers each TKR as an independent operation. However, studies on mortality concern the survival of patients and not knees. Thus, for bilateral operations only the first replaced knee was selected. Between 1975 and 2002, 65 515 patients with osteoarthritis were registered as having their first primary TKR. For these, a survival curve was calculated using the Kaplan-Meier method and the related expected survival curve was estimated using the Hakulinen method. 7 A subset of 57 979 patients who had undergone TKR between 1980 and 2002 was used for most of our calculations including the cause of death, because this information was only available for this period. In both groups the mean age at operation was 71 years (25 to 96) and the proportion of women was 65%. The first group allowed us to demonstrate the survival of patients with TKR for up to 28 years after surgery.
The underlying cause of death was registered and coded using versions 8 to 10 of the International Classification of Diseases (ICD). 8 Data on the cause of death were obtained from the National Register of Deaths 9 of The National Board of Health and Welfare, Stockholm.
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We compared the observed number of deaths with an expected number based on the mortality of the general Swedish population. The latter was calculated using the national cause of death, age, gender and calendar-yearspecific mortality rates provided by the Swedish Cause of Death Register (Statistics Sweden 10 ). Standardised mortality ratios were calculated as the observed number of deaths relative to the expected number and were tested for statistical significance using Poisson analysis. 11, 12 Proportional mortality ratios (the observed proportion of a cause of death relative to the expected proportion), were calculated to describe relative mortality and were also tested for significance. Statistical analysis. Statistical significance was set at p ≤ 0.05, and 95% confidence intervals (CI) were calculated for the standardised and proportional mortality ratios. The statistical calculations were performed using the commercial software packages STATA (Stata Corp LP, College Station, Texas) and SAS (SAS Institute Inc, Cary, North Carolina).
Results
The total follow-up in the group of 65 515 patients operated on between 1975 and 2003 was 431 139 personyears. Their survival is illustrated in Figure 1 which shows that the observed survival in patients with TKR was initially higher than that expected for the general population, but after approximately 12 years became lower than expected.
For the subgroup of 57 979 patients operated on between 1980 and 2002 the total follow-up was 382 427 person-years. Because of the progressive increase in the number of operations per year and because most operations are performed on elderly patients, only a minority of 11 741 (20.3%) had a follow-up exceeding ten years. Therefore the overall mortality and the cause-specific mortality in terms of standardised mortality ratios indicated a generally increased longevity for the study population (Table I) .
However, when studying the effect of age we found an inverse relationship between age at operation and mortality (Table II) . Patients younger than 55 years of age at operation had a statistically significant increase in total mortality while patients older than 65 years had a statistically significant decrease.
The cause-specific mortality in the subgroup of 2022 patients younger than 55 years of age at operation is given in Table III . The dominant diseases causing death were those of the circulatory system.
Patients aged 55 years or more at operation had a statistically significant reduction in mortality from most causes (Table IV) .
However, when studying relative cause-specific mortality in patients aged 55 years and older at operation the same causes of death were over-represented in patients younger than 55 years (Table V) .
An increased mortality from musculoskeletal disorders was apparent in our study. In order to investigate if this was related to operative mortality we excluded deaths occurring within one year of operation. The standardised mortality ratios for musculoskeletal disorders then became close to unity.
Discussion
Data from the Norwegian Register as well as from a Medicare series in the USA have demonstrated an increased tenyear survival rate of patients with THR as compared with that of a matched series from the general population. 3, 5 The same is seen with our data.
Lengthening of the follow-up time for up to 28 years showed a different pattern. The initial reduction in overall mortality changed with time into an increased mortality (Fig. 1) . Further analysis showed that the increased longterm mortality primarily reflected an increased mortality in younger age groups rather than an increased mortality among all patients after longer follow-up. The longer the follow-up was the greater the proportion of patients operated on at a young age.
A general decreased mortality in the elderly can probably be attributed to the selection of relatively healthy elderly patients for surgery. An unwillingness of surgeons to offer surgery to patients with co-morbidities is probably also reflected by the observed under-representation of mental, neurological, and respiratory system disorders as causes of death (Table V) .
The increased mortality because of musculoskeletal disorders (Tables IV and V) appears to have been related to the initial post-operative mortality, since this disappeared when deaths during the first post-operative year were excluded.
An unspecified increased mortality among younger patients has previously also been briefly reported from the Norwegian Hip Arthroplasty Register. 3 We found a statistically significant increase in cardiovascular mortality. The increase in mortality was restricted to younger patients. However, while older patients had a reduced overall mortality, cardiovascular causes of death were still relatively over-represented. It is of interest that increased cardiovascular mortality has also been reported in rheumatoid arthritis, [13] [14] [15] inflammatory conditions 16 and recently after treatment with certain anti-inflammatory drugs. 17, 18 Concerning the young patients, the question arises whether the increased mortality was an effect of selection of patients who were less healthy for joint replacement. The observed increase in cardiovascular mortality needs further investigation to identify if it is related to osteoarthritis or its treatment. Regarding urogenital and gastrointestinal diseases we believe that a confounding selection for joint replacement would be less likely since such diseases may be more associated with infections. Long-term treatment with Cox 1 and 2 inhibitors and other nephrotoxic medication, metal ion excretion through the kidney from the implants, or associated lifestyle choices such as smoking and ingestion of alcohol may be part of the explanation, but this needs further evaluation.
The strength of our study is that we were able to report on large numbers of patients with a long follow-up and to correlate their outcome with official Swedish death registers. The weakness is that although there was only one principal cause of death there may have been other contributory causes which were not recorded. It was also impossible to know if the observed increase in mortality was caused by the selection of patients, morbidity caused by the disease or iatrogenic factors. However, we feel that the observation that TKR under the age of 50 years for osteoarthritis is linked to an increased mortality should be a reason for increased general awareness of health problems among these patients.
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